Boyle-Vavra Susan, Ereshefsky Ben, Wang Chih-Chien, Daum Robert S
Department of Pediatrics, Section of Infectious Diseases, University of Chicago, IL, 60637, USA.
J Clin Microbiol. 2005 Sep;43(9):4719-30. doi: 10.1128/JCM.43.9.4719-4730.2005.
Methicillin-resistant Staphylococcus aureus (MRSA) isolates carry the methicillin resistance gene (mecA) on a horizontally transferred genetic element called the staphylococcal chromosome cassette mec (SCCmec). Community-acquired MRSA (CAMRSA) isolates usually carry SCCmec type IV. We previously reported that 76% of 17 CAMRSA isolates (multilocus sequence type 59) obtained from pediatric patients with skin and soft tissue infections (SSTI) from Taipei did not carry SCCmec types I to IV. We used DNA sequence analysis to determine that the element harbored by these nontypeable isolates is a novel subtype of SCCmec V called SCCmec V(T.) It contains a ccrC recombinase gene variant (ccrC2) and mec complex C2. One SSTI isolate contained molecular features of SCCmec IV but also contained ccrC2 (a feature of SCCmec V(T)), suggesting that it may harbor a composite SCCmec element. The genes lukS-PV and lukF-PV encoding the Panton-Valentine leukocidin (PVL) were present in all CAMRSA SSTI isolates whether they contained SCCmec type IV or V(T). SCCmec V(T) was also present in 5 of 34 (14.7%) CAMRSA colonization isolates collected from healthy children from Taipei who lacked MRSA risk factors. Four (80%) of the these isolates contained lukS-PV and lukF-PV, as did 1 of 27 (3.7%) SCCmec IV-containing colonization isolates. A total of 63% (10 of 16) of the SSTI isolates and 61.7% (21 of 34) of the colonization isolates tested were resistant to at least four classes of non-beta-lactam antimicrobials. SCCmec V(T) is a novel SCCmec variant that is found in multiply resistant CAMRSA strains with sequence type 59 in Taipei in association with the PVL leukotoxin genes.
耐甲氧西林金黄色葡萄球菌(MRSA)分离株在一种名为葡萄球菌染色体盒式mec(SCCmec)的水平转移遗传元件上携带甲氧西林抗性基因(mecA)。社区获得性MRSA(CAMRSA)分离株通常携带IV型SCCmec。我们之前报道,从台北患有皮肤和软组织感染(SSTI)的儿科患者中分离出的17株CAMRSA(多位点序列类型59)中,76%不携带I至IV型SCCmec。我们通过DNA序列分析确定,这些不可分型分离株所携带的元件是SCCmec V的一种新型亚型,称为SCCmec V(T)。它包含一个ccrC重组酶基因变体(ccrC2)和mec复合体C2。一株SSTI分离株具有IV型SCCmec的分子特征,但也含有ccrC2(SCCmec V(T)的一个特征),这表明它可能携带一个复合SCCmec元件。编码杀白细胞素(PVL)的基因lukS-PV和lukF-PV存在于所有CAMRSA SSTI分离株中,无论它们含有IV型还是V(T)型SCCmec。SCCmec V(T)也存在于从台北无MRSA危险因素的健康儿童中收集的34株CAMRSA定植分离株中的5株(14.7%)。这些分离株中有4株(80%)含有lukS-PV和lukF-PV,含IV型SCCmec的27株定植分离株中有1株(3.7%)也含有这两个基因。测试的SSTI分离株中有63%(16株中的10株)和定植分离株中有61.7%(34株中的21株)对至少四类非β-内酰胺类抗菌药物耐药。SCCmec V(T)是一种新型的SCCmec变体,在台北具有序列类型59的多重耐药CAMRSA菌株中发现,与PVL白细胞毒素基因相关。